4/19
02:07 am
lpcn
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
4/11
11:21 am
lpcn
Cirrhosis Market and Pipeline Insights, 2024: Analysis of Emerging Drugs GXHPC 1 (GWOXI Stem Cell Applied Technology), LPCN 1148 (Lipocine), and Belapectin (Galectin Therapeutics) [Yahoo! Finance]
Medium
Report
Cirrhosis Market and Pipeline Insights, 2024: Analysis of Emerging Drugs GXHPC 1 (GWOXI Stem Cell Applied Technology), LPCN 1148 (Lipocine), and Belapectin (Galectin Therapeutics) [Yahoo! Finance]
4/11
07:22 am
lpcn
Lipocine Announces Positive LPCN 2401 Clinical Results Showing Improved Body Composition in Participants with Obesity [Yahoo! Finance]
Medium
Report
Lipocine Announces Positive LPCN 2401 Clinical Results Showing Improved Body Composition in Participants with Obesity [Yahoo! Finance]
4/11
07:00 am
lpcn
Lipocine Announces Positive LPCN 2401 Clinical Results Showing Improved Body Composition in Participants with Obesity
Low
Report
Lipocine Announces Positive LPCN 2401 Clinical Results Showing Improved Body Composition in Participants with Obesity
4/11
02:04 am
lpcn
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
4/3
02:04 am
lpcn
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/28
08:09 am
lpcn
Lipocine Announces Positive Week 52 Results from LPCN 1148 Phase 2 Study in Patients with Cirrhosis [Yahoo! Finance]
High
Report
Lipocine Announces Positive Week 52 Results from LPCN 1148 Phase 2 Study in Patients with Cirrhosis [Yahoo! Finance]
3/28
08:00 am
lpcn
Lipocine Announces Positive Week 52 Results from LPCN 1148 Phase 2 Study in Patients with Cirrhosis
Low
Report
Lipocine Announces Positive Week 52 Results from LPCN 1148 Phase 2 Study in Patients with Cirrhosis
3/26
02:32 am
lpcn
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
High
Report
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/25
01:05 pm
lpcn
Cirrhosis Clinical Trial Pipeline Insights Featuring 45+ Companies | DelveInsight [Yahoo! Finance]
Medium
Report
Cirrhosis Clinical Trial Pipeline Insights Featuring 45+ Companies | DelveInsight [Yahoo! Finance]
3/25
08:06 am
lpcn
Lipocine Announces First Cohort Dosed in Pivotal Study of LPCN 1154 [Yahoo! Finance]
Medium
Report
Lipocine Announces First Cohort Dosed in Pivotal Study of LPCN 1154 [Yahoo! Finance]
3/25
08:00 am
lpcn
Lipocine Announces First Cohort Dosed in Pivotal Study of LPCN 1154
Medium
Report
Lipocine Announces First Cohort Dosed in Pivotal Study of LPCN 1154
3/18
02:14 am
lpcn
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/10
01:01 am
lpcn
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/7
08:08 am
lpcn
Lipocine Announces Financial Results for the Full Year Ended December 31, 2023 [Yahoo! Finance]
Low
Report
Lipocine Announces Financial Results for the Full Year Ended December 31, 2023 [Yahoo! Finance]
3/7
08:00 am
lpcn
Lipocine Announces Financial Results for the Full Year Ended December 31, 2023
Medium
Report
Lipocine Announces Financial Results for the Full Year Ended December 31, 2023
3/6
08:11 am
lpcn
Lipocine to Present at 36th Annual Roth Conference [Yahoo! Finance]
Medium
Report
Lipocine to Present at 36th Annual Roth Conference [Yahoo! Finance]
3/6
08:00 am
lpcn
Lipocine to Present at 36th Annual Roth Conference
Medium
Report
Lipocine to Present at 36th Annual Roth Conference
3/2
02:02 am
lpcn
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
2/23
02:13 am
lpcn
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
2/15
01:14 am
lpcn
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
2/7
04:05 am
lpcn
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
2/6
08:19 am
lpcn
Lipocine Announces Confirmation of Dosing Regimen for Pivotal Study of LPCN 1154 [Yahoo! Finance]
Low
Report
Lipocine Announces Confirmation of Dosing Regimen for Pivotal Study of LPCN 1154 [Yahoo! Finance]
2/6
08:00 am
lpcn
Lipocine Announces Confirmation of Dosing Regimen for Pivotal Study of LPCN 1154
Low
Report
Lipocine Announces Confirmation of Dosing Regimen for Pivotal Study of LPCN 1154
2/2
08:12 am
lpcn
Lipocine Announces Continued Commercialization of TLANDO® through Verity Pharmaceuticals [Yahoo! Finance]
Medium
Report
Lipocine Announces Continued Commercialization of TLANDO® through Verity Pharmaceuticals [Yahoo! Finance]